Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Elisabeth Russ"'
Autor:
Aurélie Maran-Gonzalez, Christian Garbar, Magali Lacroix-Triki, Marie-Mélanie Dauplat, Emmanuelle Charafe-Jauffret, Eva Brabencova, Isabelle Treilleux, Marie-Christine Mathieu, Véronique Becette, Pascal Roger, Cécile Blanc-Fournier, Paul Delrée, Anca Berghian, Camille Franchet, Juliette Haudebourg, Gaëtan MacGrogan, Martine Antoine, Frédérique Penault-Llorca, Elisabeth Russ, C. Barlier, Yves Marie Robin, Anne Vincent-Salomon, Laurent Arnould, Jean-Pierre Ghnassia, Clémence Fleury, Alexander Valent, Patrick Michenet, Raphaëlle Duprez-Paumier, Marie-Pierre Chenard, Bruno Poulet, Véronique Verriele
Publikováno v:
Annales de Pathologie. 39:383-398
Neoadjuvant therapy is an increasing treatment option in the management of breast cancer. The tumor response to neoadjuvant therapy, especially the pathological complete response, is a validated endpoint frequently used in clinical trials. However, t
Autor:
Bruno Poulet, Alexander Valent, Jean-Pierre Ghnassia, Gaëtan MacGrogan, Lounes Djerroudi, Véronique Becette, Aurélie Maran-Gonzalez, Emmanuelle Charafe-Jauffret, Olivia Abramovici, Marie-Mélanie Dauplat, Cécile Blanc-Fournier, Yves Marie Robin, Agnès Leroux, Isabelle Treilleux, Frédérique Penault-Llorca, Elisabeth Russ, Paul Delrée, Eva Brabencova, Magali Lacroix-Triki, Pascal Roger, Juliette Haudebourg, Martine Antoine, Anca Berghian, Véronique Verriele, Patrick Michenet, Raphaëlle Duprez-Paumier, Marie-Pierre Chenard, Clémence Fleury, Anne Vincent-Salomon, Camille Franchet, Laurent Arnould, Lucie Tixier, Pour le Gefpics, Marie-Christine Mathieu
Publikováno v:
Annales de Pathologie
Annales de Pathologie, Elsevier Masson, 2021, ⟨10.1016/j.annpat.2021.07.014⟩
Annales de Pathologie, Elsevier Masson, 2021, ⟨10.1016/j.annpat.2021.07.014⟩
The last international guidelines on HER2 determination in breast cancer have been updated in 2018 by the American Society of Clinical Oncology and College of American Pathologists, on the basis of a twenty-year practice and results of numerous clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::292f83395888c73d5447eb356730dcd1
https://hal.archives-ouvertes.fr/hal-03333764
https://hal.archives-ouvertes.fr/hal-03333764
Autor:
Elisabeth Russe, Sandra Scharfetter, Fabian Köninger, Mark Rinnerthaler, Gottfried Wechselberger
Publikováno v:
JPRAS Open, Vol 39, Iss , Pp 223-227 (2024)
Summary: Migraine affects more than 1 billion people globally, with distinct genetic variations influencing susceptibility. Thereby, genetic variations play a key role in the probability of developing migraine. However, personalized genetic analysis-
Externí odkaz:
https://doaj.org/article/01f241ebf0a64bde938d0524b42be08d
Autor:
Elisabeth Russ
Publikováno v:
Annales de Pathologie. 37:380-384
Autor:
Elisabeth Russ
Publikováno v:
Annales de Pathologie. 37:385-388
Autor:
Elisabeth Russ, Bruno Boyer
Publikováno v:
Imagerie de la Femme. 25:56-63
Resume Un resultat benin apres un prelevement mammaire est l’eventualite la plus frequente mais doit etre gere de facon rigoureuse et critique pour ne pas meconnaitre un faux-negatif. Les auteurs abordent pour chaque type de prelevement (biopsie so
Autor:
Krishna B. Clough, Pedro F. Gouveia, Isabelle Sarfati, Elisabeth Russ, Eleanore Massey, Claude Nos, Djazia Benyahi
Publikováno v:
Annals of Surgical Oncology. 22:4247-4253
Oncoplastic techniques applied to breast-conserving surgery (BCS) allow large-volume resections without compromising cosmetic results. Level II oncoplastic techniques are based on mammoplasties. When required, they allow resection of more than 20 % o
Autor:
Elisabeth, Russ
Publikováno v:
Annales de pathologie. 37(5)
Autor:
Elisabeth, Russ
Publikováno v:
Annales de pathologie. 37(5)
Autor:
Raquel F. D. van la Parra, Najeeb Halabi, Krishna B. Clough, Claude Nos, Isabelle Sarfati, Helene H. Thygesen, Eric Levy, Elisabeth Russ
Publikováno v:
Annals of surgery. 268(1)
The aim of this study was to evaluate the long-term oncologic outcome after oncoplastic surgery (OPS).OPS combines wide tumor excision with reduction mammoplasty techniques thus extending breast conserving surgery to large tumors that might else be p